ganirelix orifarm 0.25 mg/0.5 ml
orifarm generics a/s - ganireliksacetat - injeksjonsvæske, oppløsning i ferdigfylt sprøyte - 0.25 mg/0.5 ml
timosan 1 mg/ ml
2care4 aps - timololmaleat - depotøyedråper, oppløsning i endosebeholder - 1 mg/ ml
givix vet 88 mg
ceva santé animale - klindamycinhydroklorid - tyggetablett - 88 mg
givix vet 264 mg
ceva santé animale - klindamycinhydroklorid - tyggetablett - 264 mg
abrysvo
pfizer europe ma eeig - respiratory syncytial virus, subgroup a, stabilized prefusion f protein / respiratory syncytial virus, subgroup b, stabilized prefusion f protein - respiratorisk syncytialvirusinfeksjoner - vaksiner - abrysvo is indicated for:passive protection against lower respiratory tract disease caused by respiratory syncytial virus (rsv) in infants from birth through 6 months of age following maternal immunisation during pregnancy. se avsnitt 4. 2 og 5. active immunisation of individuals 60 years of age and older for the prevention of lower respiratory tract disease caused by rsv. bruk av denne vaksinen skal være i samsvar med offisielle anbefalinger.